Loading…
Loading…
GMRE (Global Medical REIT Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for GMRE and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for GMRE and 80,000+ other tickers.
See exactly how GMRE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GMRE and 80,000+ other tickers.
Global Medical REIT Inc. operates as a specialized real estate investment trust (REIT) focused on net-lease medical office properties. The company's core activity involves purchasing and subsequently leasing custom-designed healthcare facilities to well-established healthcare systems and physician practices that command a significant share of their market.
JPMorgan Chase and Co. reduced its position in shares of Global Medical REIT Inc. (NYSE: XRN) by 72.8% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 109,144 shares of the company's stock after selling 291,977 shares during the quarter. JPMorgan Chase and
Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, two have given a buy rating and one has given
FrontView REIT (NYSE: FVR - Get Free Report) and Global Medical REIT (NYSE: GMRE - Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Valuation and Earnings This table compares
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief F.
Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong